CDX2, COX2 and MUC2 Expressions in Barrett's Esophagus: Can They Be Useful in Determination of the Dysplasia? | Zendy

İlknur Türkmen | Zendy; Nuray Başsüllü | Zendy; Süleyman Uraz | Zendy; Mehmet Ali Yerdel | Zendy; Reşat Memisoglu | Zendy; Gülen Doğusoy | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CDX2, COX2 and MUC2 Expressions in Barrett's Esophagus: Can They Be Useful in Determination of the Dysplasia?

Author(s) -

İlknur Türkmen,

Nuray Başsüllü,

Süleyman Uraz,

Mehmet Ali Yerdel,

Reşat Memisoglu,

Gülen Doğusoy

Publication year - 2012

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2012.01132

Subject(s) - cdx2 , intestinal metaplasia , dysplasia , goblet cell , epithelium , esophagus , barrett's esophagus , metaplasia , pathology , immunohistochemistry , mucin 2 , columnar cell , adenocarcinoma , biology , medicine , cancer , gene expression , biochemistry , gene , homeobox

The description of Barrett's esophagus which is a risk factor for esophageal adenocarcinoma has differences, and the need of goblet cells for diagnosis is controversial. However, the pathophysiology in the metaplasia seen in Barrett's esophagus is not totally understood and new methods are searched for the assessment of progression to dysplasia. We aimed to search the immunohistochemical expression of CDX2, COX2 and MUC2 in Barrett's esophagus to detect any early evidence of intestinal metaplasia or dysplasia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research